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Introduction
Traditional medicine has been often used for 
self-medication, however, health professionals 
are reluctant to use them since the efficacy of 
traditional medicine has not been scientifically 
proven and the safety of its usage in humans 
is still low.1 Clay is a type of drug derived 
from natural resources and has been used for 
generations.2 The type of clay often used as a 
treatment is calcium bentonite, smectite group 
mineral soil composed of 80% montmorillonite 
and calcium content.2,3 
Calcium bentonite is made from mineral 
weathering and the hardening of the volcanic 
ash that occurs in the atmosphere of alkaline 
water.4 Calcium bentonite has a selective 
adsorption ability for a wide range of organic 
materials by maintaining their natural 
characteristics to match the pH of living 
things and have a surface containing negative 
electromagnetic.5,6 The adsorption properties 
of calcium bentonite depend on the form and 
surface width. The greater amount of surface 
area, the more chemical substances that can 
be bound and the pores can be completely 
filled in. The dry form of calcium bentonite has 
been widely used as an antiseptic and antidote 
for bacteria and chemical poisoning.2,7 
Research on calcium bentonite safety 
is needed to develop bentonite into a 
phytopharmaca. One of the methods to 
determine the toxicity classification is based 
on the value of LD50 or median lethal dose of 
a substance.1,7 LD50 is a statistically calculated 
dose of a substance that causes death in 50% 
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Abstract
Background: Calcium bentonite is a type of clay produced by a devitrification of volcanic ash which is 
often used as a traditional medicine to absorb toxins and waste products of metabolism. The aim of this 
study was to determine the lethal dose of calcium bentonite in Wistar rats to explore its toxicity level 
and safe use.
Methods: Fifty male and female Wistar rats were randomly divided into five groups for each sex. The 
control group was given 5 cc aquadest whereas the other four groups received calcium bentonite 
solution of 50 mg/kgBW, 300 mg/kgBW, 2,000 mg/kgBW, and 5,000 mg/kgBW, respectively, at a single 
dose. The weight was observed for up to 7 days and analyzed using the unpaired t-test and Mann-
Whitney test. The death rate was calculated using the probit analysis. Median lethal dose results were 
then classified according to Loomis Criteria. 
Results: No deaths occurred at the highest dose, suggesting that the median lethal dose value of calcium 
bentonite was >5,000 mg/kgBW. No weight loss occurred due to the administration of calcium bentonite 
and a significant increase in the body weight was even observed in the male rat group. Interestingly, a 
significant decrease was found in the female rats group when compared to the control group.
Conclusions: Calcium bentonite is classified as a practically non-toxic material with a median lethal 
dose of over 5,000 mg/kgBW. 
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of the research subject.7 The aim of this study 
was to determine the median lethal dose 
of calcium bentonite in Wistar rats (Rattus 
novergicus), therefore, the toxicity level can be 
classified, as well as the safety usage.
 
Methods
This study was carried out from October−
November 2012 in the Animal Laboratory 
of the Department of Pharmacology and 
Therapy Faculty of Medicine Universitas 
Padjadjaran. The protocol study was approved 
by the Research Ethics Committee Faculty of 
Medicine Universitas Padjadjaran no 204/ 
UN6.C2.1.2/KEPK/2012. Calcium bentonite 
was obtained from the Chemical Laboratory, 
Faculty of Mathematics and Science Education, 
Universitas Pendidikan Indonesia that was 
taken from Karangnunggal, Tasikmalaya, 
Jawa Barat, Indonesia. Laboratory tests were 
performed to confirm the accuracy of the 
calcium bentonite substance at the Chemistry 
Laboratory, Bandung Institute of Technology.
Fifty healthy male and female Wistar rats 
(Rattus novergicus) aged 8−12 weeks old 
and 200±50 g weight were used. All rats were 
housed in a homogenous temperature and 
dark-light cycle for 7 days with ad libitum 
access to food and drink. Calcium bentonite 
powder was weighed using digital scales in 
accordance with the dose of each treatment 
group and further dissolved in aquadest 
of 5 ccs. The Wistar rats have fasted for 24 
hours before the administration of calcium 
bentonite.8
The rats were randomly divided into five 
groups for each sex. The control group was 
given 5 cc aquades and four other groups 
received a single dose of calcium bentonite 
solution given per sonde with a dosage of 50 
mg/kgBW, 300 mg/kgBW, 2,000 mg/kgBW, 
and 5,000 mg/kgBW, respectively.7 The routine 
weighing was conducted in all Wistar rats for 
up to 7 days after treatment and the standard 
food after the treatment was given. 
All dead rats were counted after the 
administration of a single dose of calcium 
bentonite. Data from the dead animals were 
calculated using probit analysis and then the 
results were classified into the toxicity criteria 
based on Loomis.8
Normality and homogeneity of the body 
weight data were tested using the Saphiro-
Wilk. Data between treatment groups and a 
control group were statistically analyzed using 
unpaired T-Test and Mann Whitney.
Results 
There were no deaths in both male and female 
rats up to 7 days after the administration up to 
the highest dose of 5,000 mg/kgBW at a single 
dose of oral calcium bentonite. Therefore, the 
graphic from probit analysis for this study was 
not available. Similiarly, the LD50 value of a 
single dose of calcium bentonite could not be 
calculated because as there were no dead rats. 
The body weight in male and female rats 
from routine weighing in 7 days was depicted 
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Figure 1 Changes of Mean Body weight (g) in Male Rats Observed in 7 days After a Single-
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in Figure 1 and 2. All of the groups gained 
weight and there was no decrease in body 
weight by 10% from the initial weight.
Shapiro-Wilk test or Normality test results 
showed abnormal distribution in male group 
data (p<0.05) and normal distribution for 
female group data (p>0.05). Compared to 
control group, male rats had significant 
different in body weight using dose of 300, 
2,000 and 5,000 mg/kgBW with significance 
of p=0.047, 0.009, and 0.009 respectively 
as shown in Table 1. On the contrary, a 
significant decrease was observed in the 
average body weight of female rats between 
group 3 compared with the control group 
(193.6±14.74 vs 216.60±15.14; p=0.041), 
whereas no significant difference, with other 
groups.
Table 1 Body Weight among Male Rats in Treatment Groups compared with the Control Group
Median  (minimum−maximum) P value
Group 1 dose 50 mg/kgBW 212 (187-248) 0.465
Group 2 dose 300 mg/kgBW 237 (187-248) 0.047*
Group 3 dose 2,000 mg/kgBW 272 (265-306) 0.009*
Group 4 dose 5,000 mg/kgBW 324 (308-351) 0.009*
Group 5  control 221 (198-236)
Note: P-value comparing the group with control group unpaired t-test. * statistically different compared with the control 
group
Figure 2 Changes of Mean Body weight (g) in Female Rats Observed in 7 days After a Single-






Table 2 Body Weight among Female Rats in Treatment Groups compared with the Control Group
Body weight
Mean±S.D P-value
Group 1 dose 50 mg/kgBW 211.80±9.41 0.564
Group 2 dose 300 mg/kgBW 211±20.63 0.638
Group 3 dose 2,000 mg/kgBW 193.6±14.74 0.041*
Group 4 dose 5,000 mg/kgBW 229.20±12.56 0.190
Group 5 control 216.60±15.14
Note: P-value comparing the group with control group unpaired t-test. * statistically different compared with the control 
group
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Discussion
Our study has explored the lethal dose of 
calcium bentonite in Wistar rats (Rattus 
novergicus), resulting in no difference of 
LD50 value between male and female rats, 
thus all subjects have the same sensitivity 
to the material and no gender variation.10 
Furthermore, it is apparent that LD50 of 
calcium bentonite >5,000 mg/kgBW has 
been shown as practically non-toxic materials 
according to Loomis Criteria.8 
After 7 days of administration of single-
dose oral calcium bentonite, there is an 
increase in body weight daily (Figure 1 and 
2). Furthermore, calcium bentonite has no 
toxic effect on the growth and development of 
the Wistar rats’ body weight. The substances 
would have significant side effects if there is 
a weight loss of more than 10% from their 
baseline and significant differences or changes 
of body weight between treatment groups 
compared with the control group.8,10
Interestingly, we found a significant 
increase in the average body weight between 
group 2 (dose 300 mg/kgBW), group 3 (dose 
2,000 mg/kgBW), and group 4 (dose 5,000 
mg/kgBW) compared with the control group 
(p<0.05), suggesting that a single dose of oral 
calcium bentonite does not suppress appetite 
and do not interfere with the metabolism of 
nutrients coming from food or drink.12
However, there is a significant decrease in 
the average body weight in female rat groups 
between group 3 (dose 2,000 mg/kgBW) 
compared with the control group, but routine 
measurement showed there was no body 
weight loss of more than 10% from the initial 
weight in that group. Therefore, body weight 
loss is not affected by the administration of 
calcium bentonite and probably due to the 
hormonal and metabolic effects of female 
rats.10
Our findings are consistent with the safety 
data sheet from the ThermoFisher Scientific 
and the Carl Roth Company, in which the LD50 
value of oral bentonite is more than 5,000 mg/
kgBW.11,12 Substances with LD50 values higher 
than 5,000 mg/kgBW by the oral route are 
regarded as being safe or practically non-toxic 
based on Loomis criteria.8,12 
The available studies on the toxicity of 
calcium bentonite indicate that the principal 
exposure pathway of concern is the inhalation 
of respirable dust by occupationally exposed 
cohorts. Bentonite itself is probably not more 
toxic than any other particulate not otherwise 
regulated. It is not classified as a carcinogen 
by any regulatory or advisory committee, but 
some bentonite may contain variable amounts 
of respirable crystalline silica, a recognized 
human carcinogen. However, the data have too 
many limitations to estimates the side effect 
of calcium bentonite for humans at current 
exposure levels.13 
Several studies have been conducted to 
study the effects of oral exposure of bentonite 
to humans. For example, the safety of bentonite 
has been evaluated when administered to 
protect the human gastrointestinal system 
from the adverse effects of aflatoxins. The 
used calcium bentonite was tested on a group 
of volunteers to determine the safety and 
tolerance of the clay itself during a short-
term experiment. The results demonstrate the 
relative safety of such material in human beings 
for example only mild gastrointestinal effects 
such as abdominal pain, bloating, constipation, 
diarrhea, and flatulence have been reported in 
some participants after receiving 1.5 and 3 g/
day for a period of 2 weeks. No significant dose-
dependent effects were observed for blood 
chemistry.14 Literature review by Moosavi4 on 
2,500 scientific articles published in PubMed 
has shown that the effect of the clay on various 
organs of the body, resulting in no side effects 
of clay when used with the right dose. 
There are several limitations to this study. 
First, histopathological examination of animal 
organs such as liver or kidneys were not 
performed, therefore, the effects of toxicity on 
a microscopically are not known. Second, there 
were no observations of toxicity symptoms 
were carried out, including motor activity, 
condition of the tail, feathers, eyes, heart, lungs, 
nasal secretions, body temperature, salivation, 
defecation, and urination due to limited tools 
for assessing these symptoms. 
In conclusion, present data suggest that a 
single-dose of oral calcium bentonite has LD50 
more than 5,000 mg/kgBW and classified 
as practically nontoxic materials based on 
Loomis criteria. Future studies should clarify 
the safe usage of multiple-dose of calcium 
bentonite to explore the prolonged toxic effect 
of the substance.
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